GDNF and Parkinson disease: Additional studies are needed to investigate this potential new class of signalling peptides, by focusing on potential metabolic/mitochondrial mechanisms and the striatal delivery of DNSP-11 (analogous to GDNF), which may have beneficial effects in the clinical treatment of neurodegenerative diseases such as PD.